We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$599M
AUM Growth
+$99.2M
(+20%)
Cap. Flow
+$49.8M
Cap. Flow
% of AUM
8.31%
Top 10 Holdings %
Top 10 Hldgs %
34.81%
Holding
710
New
83
Increased
162
Reduced
252
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$19.1M |
| 2 |
RSX
VanEck Russia ETF
RSX
|
+$14.1M |
| 3 |
iShares MSCI Turkey ETF
TUR
|
+$14M |
| 4 |
iShares MSCI South Korea ETF
EWY
|
+$10.8M |
| 5 |
iShares MSCI Thailand ETF
THD
|
+$9.11M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$16.7M |
| 2 |
Rogers Communications
RCI
|
+$6.28M |
| 3 |
TechnipFMC
FTI
|
+$5.75M |
| 4 |
PepsiCo
PEP
|
+$4.71M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$3.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 9.52% |
| 2 | Financials | 9.27% |
| 3 | Communication Services | 8.11% |
| 4 | Technology | 7.63% |
| 5 | Materials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Monster Beverage
MNST
$91.4B
| $134K | 0.02% |
4,704
+4,644
| +7,740% | +$125K |
|
302
TG Therapeutics
TGTX
$8.58B
| $132K | 0.02% |
9,834
| – | – |
|
303
State Street Financial Select Sector SPDR ETF
XLF
$56.1B
| $131K | 0.02% |
4,936
-84
| -2% | -$2.32K |
|
304
Fortuna Silver Mines
FSM
$2.59B
| $130K | 0.02% |
23,000
| – | – |
|
|
JNPR
305
DELISTED
Juniper Networks
JNPR
| $126K | 0.02% |
4,592
-6,730
| -59% | -$175K |
|
|
ALXN
306
DELISTED
Alexion Pharmaceuticals
ALXN
| $125K | 0.02% |
1,004
-151
| -13% | -$17.6K |
|
307
BioMarin Pharmaceuticals
BMRN
$11.5B
| $125K | 0.02% |
1,328
-35
| -3% | -$3.06K |
|
|
TSRO
308
DELISTED
TESARO, Inc.
TSRO
| $124K | 0.02% |
2,767
+326
| +13% | +$15.8K |
|
309
Xylem
XYL
$28.5B
| $122K | 0.02% |
1,819
+13
| +0.7% | +$944 |
|
310
Suncor Energy
SU
$77.7B
| $120K | 0.02% |
3,002
| – | – |
|
311
Vertex Pharmaceuticals
VRTX
$121B
| $119K | 0.02% |
709
| – | – |
|
|
FLIR
312
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $118K | 0.02% |
2,264
| – | – |
|
313
Progressive
PGR
$124B
| $114K | 0.02% |
1,934
| – | – |
|
314
Hasbro
HAS
$12.6B
| $112K | 0.02% |
1,214
-942
| -44% | -$82.8K |
|
315
CALL
BHP
BHP
$213B
| $112K | 0.02% |
187
+85
| +83% | +$3.68K |
|
|
316
PUT
BHP
BHP
$213B
| $112K | 0.02% |
706
+549
| +350% | +$23.8K |
|
317
BBVA Argentina
BBAR
$3.85B
| $109K | 0.02% |
8,710
+8,709
| +870,900% | +$159K |
|
318
Weyerhaeuser
WY
$17.3B
| $109K | 0.02% |
2,995
| – | – |
|
319
Texas Instruments
TXN
$255B
| $109K | 0.02% |
980
-276
| -22% | -$29.9K |
|
320
Signet Jewelers
SIG
$3.55B
| $108K | 0.02% |
1,880
-5,918
| -76% | -$261K |
|
321
Danaher
DHR
$135B
| $108K | 0.02% |
1,226
-82
| -6% | -$7.31K |
|
322
Royal Gold
RGLD
$17.1B
| $108K | 0.02% |
1,161
+80
| +7% | +$7.16K |
|
323
Lumen
LUMN
$6.53B
| $108K | 0.02% |
5,782
-12,168
| -68% | -$221K |
|
|
ATVI
324
DELISTED
Activision Blizzard
ATVI
| $108K | 0.02% |
1,410
-677
| -32% | -$47.9K |
|
325
Vulcan Materials
VMC
$36.3B
| $107K | 0.02% |
831
-1,943
| -70% | -$240K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2018 Portfolio in Review
As of Q2 2018, Exane Derivatives held 710 positions worth $599M, up 20% from $500M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Exane Derivatives deployed $49.8M of net new capital in Q2 2018, opening 83 new positions and adding to 162 existing holdings. Its largest new stake was UBS Group: 1,172,516 shares worth $18.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 9.5% of assets, down from 9.7% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $16.7M trimmed.
- Exane Derivatives's largest Q2 2018 buy was UBS Group: 1,172,516 shares worth $18.1M.
- Exane Derivatives added most to VanEck Russia ETF in Q2 2018, an estimated $14.1M increase.
- Exane Derivatives's biggest Q2 2018 reduction was Freeport-McMoran, cutting an estimated $16.7M.
- Exane Derivatives fully exited Rogers Communications in Q2 2018, selling an estimated $6.28M.
- Exane Derivatives's ten largest holdings make up 35% of its $599M portfolio in Q2 2018.
- Exane Derivatives opened 83 new positions and closed 24 in Q2 2018.
- Exane Derivatives's portfolio value rose 20% quarter-over-quarter to $599M.
Based on Exane Derivatives's 13F filing for Q2 2018, filed 19 Jul 2018.